These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic Polymorphisms of Cytochrome p450 (2C9) Enzyme in Patients with Type 2 Diabetes Mellitus in Turkmen and Fars Ethnic Groups. Rabiee M, Marjani A, Khajeniazi S, Mojerloo M. Endocr Metab Immune Disord Drug Targets; 2018; 18(6):653-661. PubMed ID: 30129421 [Abstract] [Full Text] [Related]
3. Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations. Teh LK, Subramaniam V, Tuan Abdu Aziz TA, Lee LS, Ismail MI, Yu CY, Ang GY, James Johari R, Ismet RI, Sahak NS, Ahmad A, Rahman TA, Nor Ghazali FM, Shaari S, Omar M, Ismail AI, Md Isa K, Salleh H, Salleh MZ. Drug Metab Pharmacokinet; 2016 Aug; 31(4):304-13. PubMed ID: 27325019 [Abstract] [Full Text] [Related]
4. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study. Saldaña-Cruz AM, León-Moreno LC, Sánchez-Corona J, Santiago DA, Mendoza-Carrera F, Castro-Martínez XH, García-Zapién AG, Morán-Moguel MC, Flores-Martínez SE. Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498 [Abstract] [Full Text] [Related]
5. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP2C9 in a Chinese Tibetan population. Jin T, Geng T, He N, Shi X, Wang L, Yuan D, Kang L. Gene; 2015 Aug 10; 567(2):196-200. PubMed ID: 25958051 [Abstract] [Full Text] [Related]
6. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. Zand N, Tajik N, Moghaddam AS, Milanian I. Clin Exp Pharmacol Physiol; 2007 Aug 10; 34(1-2):102-5. PubMed ID: 17201743 [Abstract] [Full Text] [Related]
12. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia. Jakovski K, Nestorovska AK, Labacevski N, Dimovski AJ. Pharmazie; 2013 Nov 10; 68(11):893-8. PubMed ID: 24380239 [Abstract] [Full Text] [Related]
13. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance. Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI. Int J Clin Pharmacol Ther; 2015 Jul 10; 53(7):504-16. PubMed ID: 25943175 [Abstract] [Full Text] [Related]
17. Genetic polymorphisms analysis of drug-metabolizing enzyme CYP2C9 in the Uyghur population. Jin T, Xun X, Du S, Geng T, Wang H, Feng T, Chen C, Yuan D, Kang L. Xenobiotica; 2016 Aug 10; 46(8):709-14. PubMed ID: 26610168 [Abstract] [Full Text] [Related]
20. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China. Yang ZF, Cui HW, Hasi T, Jia SQ, Gong ML, Su XL. Genet Mol Res; 2010 Sep 14; 9(3):1844-51. PubMed ID: 20845310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]